An ISO 9001:2015 Certified Firm
A Leading and Comprehensive Intellectual Property (IP) Asset Management and Litigation Support Practice
An ISO 9001:2015 Certified Firm
A Leading and Comprehensive Intellectual Property (IP) Asset Management and Litigation Support Practice
Invention relates to the field of novel anticancer agents. Compounds shown in figure are useful for the treatment of cancer, AIDS, HIV infections and asthma.
Status of Patent: US Patent 7332629